GlassScriptPhysician profile
Jeffery Dick Willden
NPI 1831243294
$1,300.64
in general payments reported to CMS, 2019-2025
28 companies · $82.61 in 2025
The $82.61 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $48.32 · 2021: $390 · 2022: $367 · 2023: $139 · 2024: $24.37 · 2025: $82.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $332.24 | 2021-2023 | Qulipta, Ubrelvy |
| Boston Scientific Corporation | $127.15 | 2019-2025 | Watchman Flx, General - Pain Management, Superion Indirect Decompression System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.23 | 2019-2021 | |
| Pfizer INC. | $87.52 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $59.71 | 2022-2023 | Farxiga |
| Novo Nordisk INC | $56.59 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.15 | 2019-2021 | |
| Allergan, INC. | $40.27 | 2019 | |
| Amgen INC. | $37.96 | 2019-2025 | Krystexxa |
| Abbott Laboratories | $36.15 | 2021 | |
| Nevro Corp. | $34.43 | 2022 | |
| Janssen Pharmaceuticals, INC | $30.28 | 2021-2022 | |
| Lilly USA, LLC | $28.77 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $27.94 | 2023 | Optimizer |
| Inspire Medical Systems, INC. | $22.12 | 2025 | Inspire |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.09 | 2022 | |
| Sanofi-Aventis U.S. LLC | $20.01 | 2022 | |
| Exact Sciences Corporation | $18.61 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $18.36 | 2023 | Myrbetriq |
| Actelion Pharmaceuticals US, INC. | $17.68 | 2021 | |
| Lucid Diagnostics INC. | $16.41 | 2022 | |
| Alfasigma USA, INC. | $16.12 | 2021 | |
| Hologic Sales and Service, LLC | $14.95 | 2023 | Thinprep 2000 Processor, Aptima |
| Merck Sharp & Dohme LLC | $14.70 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.48 | 2022 | |
| Axonics, INC. | $14.36 | 2022 | |
| Medtronic USA, INC. | $13.42 | 2019 | |
| Acerus Pharmaceuticals Corporation | $12.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Willden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.